img

Global Molecular Pharming Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Molecular Pharming Market Research Report 2024

Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
According to MRAResearch’s new survey, global Molecular Pharming market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Pharming market research.
Key companies engaged in the Molecular Pharming industry include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech and Core Biogenesis, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Molecular Pharming were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Molecular Pharming market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Molecular Pharming market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Medicago Inc
Meristem Therapeutics S.A. (Ventria Bioscience)
Miruku
Moolec Science Limited
mozza
Nobell Foods
Agrenvec S.L
Bright Biotech
Core Biogenesis
Diamante SRL
Leaf Systems International Limited
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc
Tiamat Sciences
Segment by Type
Gene Gun
Agroinfiltration
Electroporation
Agrobacterium-Mediated Gene Transfer

Segment by Application


Recombinant Antibodies
Hormones, Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Products
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Molecular Pharming report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Pharming Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gene Gun
1.2.3 Agroinfiltration
1.2.4 Electroporation
1.2.5 Agrobacterium-Mediated Gene Transfer
1.3 Market by Application
1.3.1 Global Molecular Pharming Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Recombinant Antibodies
1.3.3 Hormones, Vaccines
1.3.4 Industrial Enzymes
1.3.5 Proteins & Protein-Based Materials
1.3.6 Technical Reagents
1.3.7 Nutritional Products
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Pharming Market Perspective (2018-2033)
2.2 Molecular Pharming Growth Trends by Region
2.2.1 Global Molecular Pharming Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Pharming Historic Market Size by Region (2018-2023)
2.2.3 Molecular Pharming Forecasted Market Size by Region (2024-2033)
2.3 Molecular Pharming Market Dynamics
2.3.1 Molecular Pharming Industry Trends
2.3.2 Molecular Pharming Market Drivers
2.3.3 Molecular Pharming Market Challenges
2.3.4 Molecular Pharming Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Pharming Players by Revenue
3.1.1 Global Top Molecular Pharming Players by Revenue (2018-2023)
3.1.2 Global Molecular Pharming Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Pharming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Pharming Revenue
3.4 Global Molecular Pharming Market Concentration Ratio
3.4.1 Global Molecular Pharming Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Pharming Revenue in 2022
3.5 Molecular Pharming Key Players Head office and Area Served
3.6 Key Players Molecular Pharming Product Solution and Service
3.7 Date of Enter into Molecular Pharming Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Pharming Breakdown Data by Type
4.1 Global Molecular Pharming Historic Market Size by Type (2018-2023)
4.2 Global Molecular Pharming Forecasted Market Size by Type (2024-2033)
5 Molecular Pharming Breakdown Data by Application
5.1 Global Molecular Pharming Historic Market Size by Application (2018-2023)
5.2 Global Molecular Pharming Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Pharming Market Size (2018-2033)
6.2 North America Molecular Pharming Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Pharming Market Size by Country (2018-2023)
6.4 North America Molecular Pharming Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Pharming Market Size (2018-2033)
7.2 Europe Molecular Pharming Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Pharming Market Size by Country (2018-2023)
7.4 Europe Molecular Pharming Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Pharming Market Size (2018-2033)
8.2 Asia-Pacific Molecular Pharming Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Pharming Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Pharming Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Pharming Market Size (2018-2033)
9.2 Latin America Molecular Pharming Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Pharming Market Size by Country (2018-2023)
9.4 Latin America Molecular Pharming Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Pharming Market Size (2018-2033)
10.2 Middle East & Africa Molecular Pharming Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Pharming Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Pharming Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medicago Inc
11.1.1 Medicago Inc Company Detail
11.1.2 Medicago Inc Business Overview
11.1.3 Medicago Inc Molecular Pharming Introduction
11.1.4 Medicago Inc Revenue in Molecular Pharming Business (2018-2023)
11.1.5 Medicago Inc Recent Development
11.2 Meristem Therapeutics S.A. (Ventria Bioscience)
11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Detail
11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Introduction
11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2018-2023)
11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
11.3 Miruku
11.3.1 Miruku Company Detail
11.3.2 Miruku Business Overview
11.3.3 Miruku Molecular Pharming Introduction
11.3.4 Miruku Revenue in Molecular Pharming Business (2018-2023)
11.3.5 Miruku Recent Development
11.4 Moolec Science Limited
11.4.1 Moolec Science Limited Company Detail
11.4.2 Moolec Science Limited Business Overview
11.4.3 Moolec Science Limited Molecular Pharming Introduction
11.4.4 Moolec Science Limited Revenue in Molecular Pharming Business (2018-2023)
11.4.5 Moolec Science Limited Recent Development
11.5 mozza
11.5.1 mozza Company Detail
11.5.2 mozza Business Overview
11.5.3 mozza Molecular Pharming Introduction
11.5.4 mozza Revenue in Molecular Pharming Business (2018-2023)
11.5.5 mozza Recent Development
11.6 Nobell Foods
11.6.1 Nobell Foods Company Detail
11.6.2 Nobell Foods Business Overview
11.6.3 Nobell Foods Molecular Pharming Introduction
11.6.4 Nobell Foods Revenue in Molecular Pharming Business (2018-2023)
11.6.5 Nobell Foods Recent Development
11.7 Agrenvec S.L
11.7.1 Agrenvec S.L Company Detail
11.7.2 Agrenvec S.L Business Overview
11.7.3 Agrenvec S.L Molecular Pharming Introduction
11.7.4 Agrenvec S.L Revenue in Molecular Pharming Business (2018-2023)
11.7.5 Agrenvec S.L Recent Development
11.8 Bright Biotech
11.8.1 Bright Biotech Company Detail
11.8.2 Bright Biotech Business Overview
11.8.3 Bright Biotech Molecular Pharming Introduction
11.8.4 Bright Biotech Revenue in Molecular Pharming Business (2018-2023)
11.8.5 Bright Biotech Recent Development
11.9 Core Biogenesis
11.9.1 Core Biogenesis Company Detail
11.9.2 Core Biogenesis Business Overview
11.9.3 Core Biogenesis Molecular Pharming Introduction
11.9.4 Core Biogenesis Revenue in Molecular Pharming Business (2018-2023)
11.9.5 Core Biogenesis Recent Development
11.10 Diamante SRL
11.10.1 Diamante SRL Company Detail
11.10.2 Diamante SRL Business Overview
11.10.3 Diamante SRL Molecular Pharming Introduction
11.10.4 Diamante SRL Revenue in Molecular Pharming Business (2018-2023)
11.10.5 Diamante SRL Recent Development
11.11 Leaf Systems International Limited
11.11.1 Leaf Systems International Limited Company Detail
11.11.2 Leaf Systems International Limited Business Overview
11.11.3 Leaf Systems International Limited Molecular Pharming Introduction
11.11.4 Leaf Systems International Limited Revenue in Molecular Pharming Business (2018-2023)
11.11.5 Leaf Systems International Limited Recent Development
11.12 ORF Genetics
11.12.1 ORF Genetics Company Detail
11.12.2 ORF Genetics Business Overview
11.12.3 ORF Genetics Molecular Pharming Introduction
11.12.4 ORF Genetics Revenue in Molecular Pharming Business (2018-2023)
11.12.5 ORF Genetics Recent Development
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Detail
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Molecular Pharming Introduction
11.13.4 Pfizer, Inc. Revenue in Molecular Pharming Business (2018-2023)
11.13.5 Pfizer, Inc. Recent Development
11.14 ProdiGene Inc
11.14.1 ProdiGene Inc Company Detail
11.14.2 ProdiGene Inc Business Overview
11.14.3 ProdiGene Inc Molecular Pharming Introduction
11.14.4 ProdiGene Inc Revenue in Molecular Pharming Business (2018-2023)
11.14.5 ProdiGene Inc Recent Development
11.15 Protalix Biotherapeutics, Inc
11.15.1 Protalix Biotherapeutics, Inc Company Detail
11.15.2 Protalix Biotherapeutics, Inc Business Overview
11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Introduction
11.15.4 Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2018-2023)
11.15.5 Protalix Biotherapeutics, Inc Recent Development
11.16 Tiamat Sciences
11.16.1 Tiamat Sciences Company Detail
11.16.2 Tiamat Sciences Business Overview
11.16.3 Tiamat Sciences Molecular Pharming Introduction
11.16.4 Tiamat Sciences Revenue in Molecular Pharming Business (2018-2023)
11.16.5 Tiamat Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Pharming Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gene Gun
Table 3. Key Players of Agroinfiltration
Table 4. Key Players of Electroporation
Table 5. Key Players of Agrobacterium-Mediated Gene Transfer
Table 6. Global Molecular Pharming Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Molecular Pharming Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Molecular Pharming Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Pharming Market Share by Region (2018-2023)
Table 10. Global Molecular Pharming Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Molecular Pharming Market Share by Region (2024-2033)
Table 12. Molecular Pharming Market Trends
Table 13. Molecular Pharming Market Drivers
Table 14. Molecular Pharming Market Challenges
Table 15. Molecular Pharming Market Restraints
Table 16. Global Molecular Pharming Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Molecular Pharming Market Share by Players (2018-2023)
Table 18. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2022)
Table 19. Ranking of Global Top Molecular Pharming Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Molecular Pharming Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Pharming Product Solution and Service
Table 23. Date of Enter into Molecular Pharming Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Pharming Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Molecular Pharming Revenue Market Share by Type (2018-2023)
Table 27. Global Molecular Pharming Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Molecular Pharming Revenue Market Share by Type (2024-2033)
Table 29. Global Molecular Pharming Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Molecular Pharming Revenue Market Share by Application (2018-2023)
Table 31. Global Molecular Pharming Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Molecular Pharming Revenue Market Share by Application (2024-2033)
Table 33. North America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Molecular Pharming Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Molecular Pharming Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Molecular Pharming Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Molecular Pharming Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Molecular Pharming Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Molecular Pharming Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Molecular Pharming Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Molecular Pharming Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Molecular Pharming Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Molecular Pharming Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Molecular Pharming Market Size by Country (2024-2033) & (US$ Million)
Table 48. Medicago Inc Company Detail
Table 49. Medicago Inc Business Overview
Table 50. Medicago Inc Molecular Pharming Product
Table 51. Medicago Inc Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 52. Medicago Inc Recent Development
Table 53. Meristem Therapeutics S.A. (Ventria Bioscience) Company Detail
Table 54. Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
Table 55. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product
Table 56. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 57. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
Table 58. Miruku Company Detail
Table 59. Miruku Business Overview
Table 60. Miruku Molecular Pharming Product
Table 61. Miruku Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 62. Miruku Recent Development
Table 63. Moolec Science Limited Company Detail
Table 64. Moolec Science Limited Business Overview
Table 65. Moolec Science Limited Molecular Pharming Product
Table 66. Moolec Science Limited Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 67. Moolec Science Limited Recent Development
Table 68. mozza Company Detail
Table 69. mozza Business Overview
Table 70. mozza Molecular Pharming Product
Table 71. mozza Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 72. mozza Recent Development
Table 73. Nobell Foods Company Detail
Table 74. Nobell Foods Business Overview
Table 75. Nobell Foods Molecular Pharming Product
Table 76. Nobell Foods Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 77. Nobell Foods Recent Development
Table 78. Agrenvec S.L Company Detail
Table 79. Agrenvec S.L Business Overview
Table 80. Agrenvec S.L Molecular Pharming Product
Table 81. Agrenvec S.L Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 82. Agrenvec S.L Recent Development
Table 83. Bright Biotech Company Detail
Table 84. Bright Biotech Business Overview
Table 85. Bright Biotech Molecular Pharming Product
Table 86. Bright Biotech Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 87. Bright Biotech Recent Development
Table 88. Core Biogenesis Company Detail
Table 89. Core Biogenesis Business Overview
Table 90. Core Biogenesis Molecular Pharming Product
Table 91. Core Biogenesis Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 92. Core Biogenesis Recent Development
Table 93. Diamante SRL Company Detail
Table 94. Diamante SRL Business Overview
Table 95. Diamante SRL Molecular Pharming Product
Table 96. Diamante SRL Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 97. Diamante SRL Recent Development
Table 98. Leaf Systems International Limited Company Detail
Table 99. Leaf Systems International Limited Business Overview
Table 100. Leaf Systems International Limited Molecular Pharming Product
Table 101. Leaf Systems International Limited Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 102. Leaf Systems International Limited Recent Development
Table 103. ORF Genetics Company Detail
Table 104. ORF Genetics Business Overview
Table 105. ORF Genetics Molecular Pharming Product
Table 106. ORF Genetics Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 107. ORF Genetics Recent Development
Table 108. Pfizer, Inc. Company Detail
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Molecular Pharming Product
Table 111. Pfizer, Inc. Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 112. Pfizer, Inc. Recent Development
Table 113. ProdiGene Inc Company Detail
Table 114. ProdiGene Inc Business Overview
Table 115. ProdiGene Inc Molecular Pharming Product
Table 116. ProdiGene Inc Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 117. ProdiGene Inc Recent Development
Table 118. Protalix Biotherapeutics, Inc Company Detail
Table 119. Protalix Biotherapeutics, Inc Business Overview
Table 120. Protalix Biotherapeutics, Inc Molecular Pharming Product
Table 121. Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 122. Protalix Biotherapeutics, Inc Recent Development
Table 123. Tiamat Sciences Company Detail
Table 124. Tiamat Sciences Business Overview
Table 125. Tiamat Sciences Molecular Pharming Product
Table 126. Tiamat Sciences Revenue in Molecular Pharming Business (2018-2023) & (US$ Million)
Table 127. Tiamat Sciences Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Pharming Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Pharming Market Share by Type: 2022 VS 2033
Figure 3. Gene Gun Features
Figure 4. Agroinfiltration Features
Figure 5. Electroporation Features
Figure 6. Agrobacterium-Mediated Gene Transfer Features
Figure 7. Global Molecular Pharming Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Molecular Pharming Market Share by Application: 2022 VS 2033
Figure 9. Recombinant Antibodies Case Studies
Figure 10. Hormones, Vaccines Case Studies
Figure 11. Industrial Enzymes Case Studies
Figure 12. Proteins & Protein-Based Materials Case Studies
Figure 13. Technical Reagents Case Studies
Figure 14. Nutritional Products Case Studies
Figure 15. Molecular Pharming Report Years Considered
Figure 16. Global Molecular Pharming Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Molecular Pharming Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Molecular Pharming Market Share by Region: 2022 VS 2033
Figure 19. Global Molecular Pharming Market Share by Players in 2022
Figure 20. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Molecular Pharming Revenue in 2022
Figure 22. North America Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Molecular Pharming Market Share by Country (2018-2033)
Figure 24. United States Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Molecular Pharming Market Share by Country (2018-2033)
Figure 28. Germany Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Molecular Pharming Market Share by Region (2018-2033)
Figure 36. China Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Molecular Pharming Market Share by Country (2018-2033)
Figure 44. Mexico Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Molecular Pharming Market Share by Country (2018-2033)
Figure 48. Turkey Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Molecular Pharming Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Medicago Inc Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 51. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 52. Miruku Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 53. Moolec Science Limited Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 54. mozza Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 55. Nobell Foods Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 56. Agrenvec S.L Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 57. Bright Biotech Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 58. Core Biogenesis Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 59. Diamante SRL Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 60. Leaf Systems International Limited Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 61. ORF Genetics Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 62. Pfizer, Inc. Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 63. ProdiGene Inc Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 64. Protalix Biotherapeutics, Inc Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 65. Tiamat Sciences Revenue Growth Rate in Molecular Pharming Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries